Day: November 10, 2023

CONSHOHOCKEN, Pa., Nov. 10, 2023 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that Carole Huntsman has been appointed Chief Commercial Officer. Ms. Huntsman was most recently Senior Vice President, Head of Specialty Care North America and U.S. Country Lead at Sanofi, where she directed 2,600 team members across multiple product launches in immunology, neurology, oncology, rare diseases, and rare blood disorders. This included executing the launch of Dupixent, a first-in-class therapy which has grown into an industry-leading medicine. In 2022, Ms. Huntsman’s business unit was responsible for over $10 billion in annual net sales. Bill Sibold, Chief Executive Officer of Madrigal, stated,...

Pursuant to the stock exchange announcement published on 21.11.2022, AS PRFoods (registry code 11560713, registered address at Pärnu mnt 141, 11314 Tallinn, Estonia; „PRFoods“ or „Issuer“) announced a partial buy-back of PRFoods notes due 22.01.2025 with ISIN code EE3300001577 (the “Notes“) issued by PRFoods on 14.01.2020 pursuant to the terms and conditions of the issue of the secured notes (as amended on 25.02.2020, 25.02.2022 and 20.09.2022) (the “Terms and Conditions“), up to a maximum aggregate amount of 15% of the aggregate principal amount of all outstanding Notes. Thereafter, PRFoods decided to prolong the period for submission of offers for buy-back, wherefore the Issuer published an announcement on 26.09.2023 on the changes in the schedule of buy-back of the Notes. The period for the submission of offers...

Upon the one-year anniversary of becoming public, Nxu becomes shelf eligible and secures flexibility for future capital raises MESA, Ariz., Nov. 10, 2023 (GLOBE NEWSWIRE) — Nxu Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company developing and manufacturing innovative EV charging and energy storage solutions for the infrastructure we need to power our electrified future, announced that it has filed a “universal shelf” registration statement on Form S-3 with the Securities and Exchange Commission (the “SEC”) and it was declared effective by the SEC on October 30, 2023. The S-3 shelf allows Nxu to raise up to $75 million in primary capital in one or more offerings over the subsequent three years. If Nxu decides to raise capital in a future offering using the shelf registration statement,...

VANCOUVER, British Columbia, Nov. 10, 2023 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, is pleased to announce that the Company will release its financial results for the third quarter of 2023 on November 23, 2023, before market. CloudMD will hold its Q3 2023 earnings conference call and webinar on November 23, 2023, at 9:30 am ET (6:30 am PT). Third Quarter Earnings Conference Call and Webinar Details: Date and Time: November 23, 2023, at 9:30 am Eastern Time (6:30 am Pacific Time) Webcast link: https://edge.media-server.com/mmc/p/5aonbacb/ About CloudMD Software & Services CloudMD is an innovative North American healthcare service provider focused on empowering healthier...

Greenwich, CT, Nov. 10, 2023 (GLOBE NEWSWIRE) — Belpointe PREP, LLC (NYSE American: OZ) (“Belpointe OZ” or the “Company”), the first publicly traded Qualified Opportunity Fund, announced that it will host an investor presentation with question and answer period on Friday, November 17 at 4:30 p.m. ET. The event will highlight the Company’s go-forward strategy from Belpointe OZ CEO Brandon Lacoff, followed by a discussion on the Company’s recent developments, performance, market trends and future outlook by members of the senior management team. “We are pleased to provide a unique opportunity for participants to interact with our leadership team and gain insights into our ongoing initiatives,” said Brandon Lacoff, CEO at Belpointe OZ. The Company encourages participants to submit their questions in advance to IR@belpointeoz.com. Event...

An Extraordinary General Meeting in Ensurge Micropower ASA (the “Company”) was held today as an electronic meeting. All proposals on the agenda were adopted in accordance with the proposals of the Company’s Board, including the approval of Tranche 2 of the private placement and a subsequent offering, both announced by the Company on 18 October 2023.  Following the issuance of the shares in Tranche 2, the Company’s share capital will be NOK 233,468,885.80, divided into 2,334,688,858 shares each with a par value of NOK 0.10.  The Extraordinary General Meeting approved a new convertible loan in the total amount of NOK 4.5 million. The loan shall carry interest at the rate of 5% per annum and matures and shall be repaid (unless the loan has been converted into shares) on 10 November 2024. The loan, including accrued...

SINGAPORE and SHANGHAI, China, Nov. 10, 2023 (GLOBE NEWSWIRE) — H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World”, “we” or “our”) a key player in the global hotel industry, today announced that it will schedule to release its unaudited financial results for the third quarter of 2023 on Friday, November 24, 2023 (Hong Kong time), after the trading hours of The Stock Exchange of Hong Kong Limited and before the opening of the U.S. market. H World’s management will host a conference call at 8 p.m. (U.S. Eastern time) on Sunday, November 26, 2023 (or 9 a.m. (Hong Kong time) on Monday, November 27, 2023) following the announcement. To join by phone, all participants must pre-register this conference call using the Participant Registration link of https://s1.c-conf.com/diamondpass/10034960-g8sm4f.html. Upon registration,...

EDEN PRAIRIE, MN,, Nov. 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced its 3rd quarter 2023 results. For the three months ended September 30, 2023:Revenue for the three months ended September 30, 2023 totaled $5.0 million, an increase of 19%, as compared to $4.2 million for the same period of 2022. This growth falls within the previously provided guidance range of an approximately 15 to 25% increase for Q3 2023 as compared to Q3 2022. Revenue for the nine months ended September 30, 2023 totaled $13.4 million, an increase of 19%, as compared to $11.2 million for the same period of 2022. 55 UltraMist® systems were sold in Q3 2023, up from 28 in Q1 2023 and 49 in Q2 2023. UltraMist®...